Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Drug Repurposing for Rare Diseases

Posted on April 27th, 2016 by in Pharma R&D

Elsevier’s partnership with a UK charity Findacure started last year with a very touching and inspirational talk from Dr. Nick Sireau, a parent of two children diagnosed with alkaptonuria. Very soon after his first child was born, Nick found himself Continue reading “Drug Repurposing for Rare Diseases” »

Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now

Posted on April 26th, 2016 by in Pharmacovigilance

A few weeks ago, the US FDA approved Inflectra (infliximab-dyyb), a biosimilar to infliximab. This is the second US biosimilar approval, suggesting others may soon be on the way—good news for companies with biosimilars pending approval and in development. Continue reading “Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now” »

The Essentials of Pharmacovigilance

Posted on April 19th, 2016 by in Pharmacovigilance

Elsevier is attending the World Drug Safety Congress in Chicago this week—an important part of the pharmaceutical industry calendar that brings together experts Continue reading “The Essentials of Pharmacovigilance” »

Green and Sustainable Chemistry Conference

Posted on April 15th, 2016 by in Chemistry

It felt like an impromptu 25th birthday party for green chemistry. What a feast of speakers there were at the Green and Sustainable Chemistry conference in Berlin last week! Continue reading “Green and Sustainable Chemistry Conference” »

  1. 1
  2. 2